Innovation in pharma

Czech drug policy shifts toward patients with rare diseases

Health 11-07-2019

The Czech government has launched a legislative initiative to improve access to most modern medications and rare disease drugs, Health Minister Adam Vojtěch told EURACTIV in an interview, adding that patients are involved in the decision-making process at a very early stage, including in drafting the law.

Health 28-06-2019

New pharma boss: Next EU Commission should be clear on how to protect innovation

The next EU Commission should take a stronger position on innovation in the pharma sector, the new leader of the European Federation of Pharmaceutical Industries and Associations (EFPIA) told EURACTIV.com in an interview.
Health 07-06-2019

EU should tackle health inequality with investments: MSD official

Every EU government should prioritise healthcare because only health citizens can be a driving force for economic growth, told EURACTIV Croatia Gabriele Grom, Vice President of MSD in Central Eastern Europe (CEE).
Health 05-06-2019

Pharma incentives reform is for the next Commission, EU official says

Stakeholders gathered in the European Public Health Alliance (EPHA) reiterated their demands to reform the incentives for pharmaceutical innovation, making a set of recommendations to the European Commission during an event in Brussels on Monday (3 June).
Health 29-05-2019

AMR incentives could be next big EU opportunity, pharma boss says

Europe could become the first region worldwide to incentivise the fight anti-microbial resistance (AMR), Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), told EURACTIV in an interview.
Health 05-04-2019

Katainen: Same level of priority for food and medicine in no-deal Brexit

Medicine supplies and food safety standards are both vital and the EU cannot prioritise one over the other in the event of a no-deal Brexit, Vice President of the Commission Jyrki Katainen said on Thursday (4 April).
Health 20-03-2019

Pharma industry urges EU leaders to ‘re-focus’ on patients post-Brexit

The EU pharma industry has prepared for a hard Brexit scenario but this is not enough as EU leaders need to take specific measures to ensure medical supplies after the UK departure, EU pharma chief Stefan Oschmann has said.   
Health 26-02-2019

Report from two EU agencies confirms superbugs as a rising threat

No decrease in resistance to antibiotics has been reported in the latest study drawn up by the EU's top two public health authorities, which should be a cause for alarm, according to the bloc's health boss, Vytenis Andriukaitis.
Health 11-02-2019

EU pharma stakeholders take action to tackle fake medicines

A number of pharma stakeholders announced on 9 February the official launch of the European Medicines Verification System (EMVS), which will make use of new technologies to improve safety in the medicines’ supply chain against fake products.
Health 29-01-2019

Pharma industry raises the alarm about stockpiling of generic drugs

The industry of innovative medicines is concerned with a recent vote in the European Parliament on the stockpiling of generic drugs, saying that it causes uncertainty over innovation in the pharmaceutical field.
Health 24-01-2019

New anti-microbial resistance business models are off the table, Romanian health minister says

Romania's EU Presidency will not look into new business models to tackle anti-microbial resistance (AMR), Romanian Health Minister Sorina Pintea told EURACTIV.com in an interview.
Health 21-01-2019

Discussion heats up over stockpiling of generic drugs under patent protection

The Commission has announced its intention to add a manufacturing waiver to supplementary protection certificates (SPC), as part of its upgraded 2015 Single Market Strategy.
Health 05-12-2018

Disparities remain on how to tackle lung cancer in Europe, report says

Enhanced prevention measures, especially against tobacco and electronic cigarettes, combined with access to innovative treatments can help tackle rising lung cancer cases in Europe, a new study funded by the industry has found.
Health 04-12-2018

Romanian health minister: Prevention and innovative drugs to kill cancer

In order to face the rising cancer incidence across Europe, governments should prioritise prevention policies, as well as access to innovative medicines under an EU-wide plan, Romanian Health Minister Sorina Pintea told EURACTIV.com in an interview.
Health 04-12-2018

Greek pharma boss: ‘We reached our limits, our sustainability is at stake’

The Greek pharmaceutical industry has reached its limits due to a number of “unreasonable” burdens imposed by the government during the crisis, Greek pharma chief Olympios Papadimitriou told EURACTIV.com in an interview. The sustainability of pharma companies is at stake, threatening 86,000 jobs, he said.
Health 25-10-2018

Does fast-track drugs approval in EU run too fast?

More than two years after its launch, the EU's fast-track approval process for marketing new drugs, called PRIME, is broadly welcomed by patients and industry, walking the fine line between patients' safety and expediency, and between the need to foster innovation and remaining abuse-proof.
Health 23-10-2018

EU generics industry slams US ‘intervention’ in SPC manufacturing waiver talks

The EU generics industry has accused the US government of intervening in the ongoing discussion in the EU on the introduction of a Supplementary Protection Certificate (SPC) manufacturing waiver.

MEP: Need for an EU-wide cancer plan to ensure long-term pharma innovation

The creation of an EU cancer plan will improve EU citizens’ medical needs and access but will also simultaneously help bring innovations to the market, through enhanced collaboration among stakeholders, according to Belgian MEP Lieve Wierinck.

Innovation in oncology – Can science make cancer a manageable disease?

In Europe, more than 3 million people are diagnosed with cancer each year. But recent advances in cancer treatment have offered new hope to those battling the disease.
Health 10-10-2018

New drugs: how much are governments paying for innovation?

The European healthcare sector is divided over the “actual value” EU governments pay for the authorised and partly public-funded novel drugs, compared to medicines already on the market.
Health 05-10-2018

Estonia and Finland first to start exchanging healthcare data by end of year

Estonia and Finland will start exchanging digital prescriptions at the end of the year, in a groundbreaking move that Estonian Health Minister Riina Sikkut said she hoped other EU countries will follow.
Health 01-10-2018

Europe’s health sector worried about post-Brexit investment dearth

Fragmented, multilingual and over-regulated: Europe is currently not an attractive place for investors and things could get worse after Brexit, experts from the life sciences industry have warned.
Health 10-07-2018

Investment in digital health and access to drugs at the core of Austrian Presidency

Austria’s EU Presidency will focus on “strong” investment in digital health as well as on regulatory issues when it comes to access to medicines, Dr Clemens Martin Auer told EURACTIV.com in an interview. Dr Clemens Martin Auer is the president of the...
Health 03-07-2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.  
Brexit 21-03-2018

‘Vital’ UK remains part of EU clinical trials, say MPs

Continued participation in EU-wide clinical trials and the Horizon 2020 research programme is ‘vital’ to the UK’s life sciences sector, according to a new cross-party report by UK MPs.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.